Abstract
Background Diabetes is one of the most serious health crises of the twenty-first century, with the World Health Organization (WHO) estimating that hyperglycemia is the third leading cause of early death globally, following high blood pressure and cigarette use. It is an important cause of blindness, kidney failure, lower limb amputation and other long-term consequences that impact significantly on quality of life. People get sick, die, and health care costs go up as a result.
Objectives Diabetes mellitus treatment outcome and determinants in patients undergoing diabetes treatments in selected hospitals in southern Ethiopia, 2021.
Methods A source population included all diabetic patients who attended chosen hospitals in southern Ethiopia. A cross-sectional study with an institutional focus was conducted in a few hospitals in southern Ethiopia. A pre-tested questionnaire was used to collect information about the patient. Following data cleaning and error checking, the data was loaded into Epi-data to eliminate errors before being exported to SPSS for analysis. The descriptive data were presented using tables and graphics. The result variable was evaluated using a logistic regression model to uncover predictors once the underlying assumptions of the regression analysis were verified. All independent variables with p0.25 were considered for multivariate analysis. The level of significance was then set at p0.05, and the final model was AOR with 95% CL.
Result 277 (65.6%) of the whole sample had positive treatment outcomes. The existence of complication AOR 95%CI; 0.425 (0.217,.832), and elevated fasting blood glucose AOR 95%CI; 0.080 (0.034, 0.188) were revealed to be independent predictors. Given the low size of treatment outcome, providing health information regarding sticking to prescribed medicine and monitoring fasting blood glucose level will result in a positive clinical outcome.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding is required to do this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
It is Hawassa university ethical and review board.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Email: - dawithoyiso2006{at}gmail.com, Email: - Knifichomed{at}gmail.com
Data Availability
The data will be deposited in public repositories.
ACRONYMS AND ABBREVIATION
- CBE
- Community based education
- DM
- Diabetes mellitus
- HUCSH
- Hawassa University Comprehensive Specialized Hospital
- WHO
- World health organization
